CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.30
+0.02 (0.35%)
At close: Jan 6, 2026, 4:00 PM EST
5.25
-0.05 (-0.94%)
After-hours: Jan 6, 2026, 7:18 PM EST
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $3.29 million as of January 6, 2026. Its market cap has decreased by -48.94% in one year.
Market Cap
3.29M
Enterprise Value
-6.48M
1-Year Change
-48.94%
Ranking
Category
Stock Price
$5.30
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $3.29M, a decrease of -95.30%. That is a compound annual growth rate of -39.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 3.29M | 0.95% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |